End
1 :

Hint : ❀️ Doxorubicin has cumulative cardiac toxicity.

Correct Answers:

  • Development of congestive heart failure.


Rationale :

πŸ’œ Doxorubicin is an anthracycline antineoplastic medication associated with dose-dependent cardiotoxicity.

πŸ’œ Repeated exposure can cause irreversible myocardial damage, resulting in decreased cardiac contractility and cardiomyopathy.

πŸ’œ The risk of developing heart failure increases as the client's cumulative lifetime dose of doxorubicin increases.

πŸ’œ For this reason, the total lifetime exposure to doxorubicin is limited to reduce the risk of severe cardiac injury.

πŸ’œ Cardiac function is commonly evaluated before and during therapy using measurements such as left ventricular ejection fraction (LVEF).

πŸ’œ Manifestations of developing heart failure can include dyspnea, fatigue, peripheral edema, pulmonary congestion, and decreased exercise tolerance.

πŸ’œ Clients should be instructed to promptly report new symptoms suggesting deterioration in cardiac function.

πŸ’œ Cumulative cardiotoxicity leading to heart failure is therefore the adverse effect that limits the lifetime amount of doxorubicin.


Distractor Analysis :

Rationale for Incorrect Options to be Available Soon

QLexNursing Calculator Click & Drag ×
AC
(
)
CE
Ο€
e
Ο†
Ο„
Inv
sin-1
cos-1
tan-1
log
ln
!
deg
√
xΒ²
xΒ³
^
7
8
9
Γ·
4
5
6
Γ—
1
2
3
-
0
.
exp
+
Rnd
Ans
=